1h-imidazo(4,5-b)pyridine has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Alam, MA; Alam, O; Haider, MR; Husain, A; Iqbal, MA; Khan, SA | 1 |
| Damghani, T; Edraki, N; Firuzi, O; Kayani, Z; Khoshneviszadeh, M; Moosavi, F; Mortazavi, M; Pirhadi, S; Saso, L | 1 |
2 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Lung Neoplasms
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of imidazopyridine-linked thiazolidinone as potential anticancer agents.
Topics: A549 Cells; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Design; Female; Humans; Imidazoles; Lung Neoplasms; Male; MCF-7 Cells; Molecular Docking Simulation; Prostatic Neoplasms; Pyridines; Rats; Rats, Wistar; Thiazolidines; Toxicity Tests | 2020 |
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Neoplastic; Humans; Hydrazones; Imidazoles; Lung Neoplasms; Molecular Docking Simulation; Molecular Dynamics Simulation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; Structure-Activity Relationship | 2021 |